The striking synergy between LAG-3 and PD-1 has been reported in murine melanoma, fibrosarcoma, and colorectal adenocarcinoma models, the combinatorial blockade against LAG-3 and PD-1 effectively eradicate most established tumors, which are largely resistant to single agent treatment. The gene discussed is LAG3; the disease is melanoma.